Genocea Biosciences Inc. (GNCA)
$0.00
$0.00
(-33.33%)
As on 24-Feb-2023 09:30EDT
Market cap
$0 Mln
Revenue (TTM)
$2 Mln
P/E Ratio
--
P/B Ratio
0
Div. Yield
0 %
Stock Range
Today’s Range
52 Week Range
Liquidity
Fundamentals
-
Net Profit (TTM)
$-37 Mln
-
ROE
-5.3 %
-
ROCE
-- %
-
Industry P/E
--
-
EV/EBITDA
0.1
-
Debt to Equity
0.2
-
Book Value
$--
-
EPS
$--
-
Face value
--
-
Shares outstanding
58,783,500
10 Years Aggregate
CFO
$-353.94 Mln
EBITDA
$-344.39 Mln
Net Profit
$-361.91 Mln
Performance
|
Company
|
YTD
|
1 Month
|
3 Months
|
1 Year
|
3 Years
|
5 Years
|
10 Years
|
|---|---|---|---|---|---|---|---|
|
Genocea Biosciences (GNCA)
| 100.0 | 100.0 | -98.7 | -100.0 | -95.5 | -88.0 | -- |
|
BSE Sensex*
| -9.1 | -1.5 | 2.9 | -3.6 | 5.9 | 6.0 | 10.5 |
|
Company
|
2022
|
2021
|
2020
|
2019
|
2018
|
2017
|
2016
|
|---|---|---|---|---|---|---|---|
|
Genocea Biosciences (GNCA)
| -100.0 | -52.1 | 16.9 | -9.8 | -75.1 | -71.8 | -21.8 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
|
BSE Sensex
| 4.4 | 22.0 | 15.8 | 14.4 | 5.9 | 27.9 | 1.9 |
Essential Checks
View DetailsIs there a threat to the company's solvency?
Can creative accounting be detected through the financial numbers?
How did the company perform in the last one year?
Financials
View DetailsKey Ratios
View Details
5Y Avg -- 3Y Avg -- TTM --
P/E Ratio
--
--Min --Median --Max
P/B Ratio
--
--Min --Median --Max
Earnings Yield (%)
--
Earnings Yield (%) = EBIT / Enterprise value
PEG Ratio
--
Price = Price / Earnings to growth ratio
Peers
View DetailsCompany |
Price ($) | Market Cap ($ Mln) | Revenue (TTM) | Net Profit (TTM) | OPM (%) | ROE (%) | P/E | P/B |
|---|---|---|---|---|---|---|---|---|
|
Genocea Biosciences (GNCA)
|
0.0 | 0.0 | 1.9 | -37.2 | -1,910.9 | -148.1 | -- | 0.0 |
| 82.4 | 11,993.9 | 669.5 | -320.0 | -0.8 | -71.1 | -- | 26.9 | |
| 70.9 | 10,022.2 | 71.0 | -894.0 | -1,175.8 | -- | -- | 60.3 | |
| 54.6 | 13,491.7 | 2,435.9 | 860.6 | 31.0 | 43 | 17.4 | 7.4 | |
| 106.5 | 11,957.0 | 1,663.7 | 413.6 | 36.3 | 430 | 30.9 | 84.5 | |
| 359.4 | 10,402.8 | 440.5 | 241.5 | 33.4 | 18.7 | 44.1 | 7.8 | |
| 540.0 | 12,332.1 | 1,283.9 | -325.1 | -19.0 | -57.7 | -- | 24.0 | |
| 594.0 | 16,765.1 | 2,782.3 | 491.5 | 21.1 | 110.1 | 35.2 | 39.3 | |
| 350.3 | 9,625.4 | 0.0 | -339.1 | -- | -30.6 | -- | 7.6 | |
| 147.8 | 9,339.4 | 282.0 | 82.9 | -28.6 | 11.4 | 140.1 | 11.5 |
Shareholding Pattern
View DetailsAbout Genocea Biosciences (GNCA)
Genocea Biosciences, Inc., a biopharmaceutical company, discovers and develops novel cancer immunotherapies. The company uses its proprietary discovery platform, ATLAS, which profiles each patient's CD4+ and CD8+ T cell immune responses to every... target or antigen identified by next-generation sequencing of that patient's tumor. Its products include GEN-011, an adoptive T cell therapy, which is in Phase 1/2a clinical trials for the treatment of solid tumors; and GEN-009, a neoantigen vaccine candidate, which is in Phase 1/2a clinical trials that delivers adjuvanted synthetic long peptides spanning ATLAS-identified anti-tumor neoantigens. The company was incorporated in 2006 and is based in Cambridge, Massachusetts. On July 5, 2022, Genocea Biosciences, Inc. filed a voluntary petition for reorganization under Chapter 11 in the U.S. Bankruptcy Court for the District of Massachusetts. Read more
-
Pres, CEO & Director
Mr. William D. Clark M.B.A.
-
Pres, CEO & Director
Mr. William D. Clark M.B.A.
-
Headquarters
Cambridge, MA
-
Website
Value Research Ratings
Our rating system has guided millions of investors in the past 20 years.
FAQs for Genocea Biosciences (GNCA)
What is the current share price of Genocea Biosciences Inc (GNCA) Today?
The share price of Genocea Biosciences Inc (GNCA) is $0.00 (NASDAQ) as of 24-Feb-2023 09:30 EDT. Genocea Biosciences Inc (GNCA) has given a return of -95.46% in the last 3 years.
What is the current PB & PE ratio of Genocea Biosciences Inc (GNCA)?
Since, TTM earnings of Genocea Biosciences Inc (GNCA) is negative, P/E ratio is not available.
The P/B ratio of Genocea Biosciences Inc (GNCA) is 0.01 times as on 24-Feb-2023, a 100 discount to its peers’ median range of 5.18 times.
PE & PB ratio at the end of financial year.
| Year | P/E Ratio | P/B Ratio |
|---|---|---|
2021 |
-- |
-- |
2020 |
-- |
-- |
2019 |
-- |
-- |
2018 |
-- |
-- |
2017 |
-- |
-- |
What is the 52 Week High and Low of Genocea Biosciences Inc (GNCA)?
The 52-week high and low of Genocea Biosciences Inc (GNCA) are Rs -- and Rs -- as of 01-Sep-2026.
What is the market cap of Genocea Biosciences Inc (GNCA)?
Genocea Biosciences Inc (GNCA) has a market capitalisation of $ 0 Mln as on 24-Feb-2023. As per SEBI classification, it is a company.
Should I invest in Genocea Biosciences Inc (GNCA)?
Before investing in Genocea Biosciences Inc (GNCA), assess your goals, risk tolerance, and if the company aligns with your long-term plan. Carefully review its business model, financials, and valuation. Avoid making decisions based on tips or short-term trends.
New Process Alert 
Seems like you've uploaded a wrong QR code. Please upload the QR code downloaded from MF Central platform.